Composite extract with hangover alleviating effect and preparation method thereof

By preparing a compound extract of Cistanche deserticola polysaccharide and dihydromyricetin, the problems of insufficient research on Cistanche deserticola polysaccharide in the field of hangover relief and the side effects of chemical hangover relief drugs in the existing technology have been solved, and a stronger hangover relief effect and a green preparation process have been achieved.

CN118976043APending Publication Date: 2024-11-19JING BRAND +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411132834.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

There is limited research on the use of Cistanche deserticola polysaccharides in relieving hangovers in existing technologies, and chemical hangover remedies have side effects. There is a lack of effective hangover remedies made from food and medicine homologous compounds.

Method used

A complex extract of Cistanche deserticola polysaccharide and dihydromyricetin was prepared by using specific process steps including extraction, precipitation, enzyme treatment, resin column separation, mixing and high pressure homogenization to form a Cistanche deserticola polysaccharide-dihydromyricetin complex.

Benefits of technology

It enhances the ability to detoxify, has a simple and environmentally friendly preparation process, and exhibits a synergistic effect between Cistanche deserticola polysaccharide and dihydromyricetin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976043A_ABST
    Figure CN118976043A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine, and particularly provides a compound extract with an effect of dispelling the effects of alcohol and a preparation method thereof.The preparation method comprises the steps that cistanche powder is extracted and concentrated with pure water to obtain a cistanche crude polysaccharide extracting solution, the crude polysaccharide extracting solution is subjected to primary alcohol precipitation, then supernate is collected, the ethanol concentration is adjusted, secondary alcohol precipitation is conducted, precipitates are collected, and the compound extract is obtained. The preparation method comprises the following steps: dissolving with pure water, carrying out enzymolysis, carrying out column purification, cooling and drying to obtain cistanche polysaccharide, mixing the cistanche polysaccharide and dihydromyricetin in proportion, carrying out ultrasonic treatment, and carrying out high-pressure homogenization and drying to obtain the cistanche polysaccharide-dihydromyricetin compound. Compared with a single substance of cistanche polysaccharide and dihydromyricetin, the compound extract has higher hangover alleviating activity. Meanwhile, the preparation process of the composite extract is simple, the composite extract is a food-grade material, and the prepared composite extract can be applied to industries such as food.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a composite extract with alcohol sobering effect and a preparation method thereof. Background Art

[0002] Cistanche deserticola YCMa is the dried fleshy stem with scale leaves of Cistanche deserticola or Cistanche tubulosa of the Orobanchaceae family. The active ingredients in Cistanche deserticola mainly include phenylethanoid glycosides, polyphenols and polysaccharides. Modern studies have shown that Cistanche deserticola polysaccharides have antioxidant, anti-aging, physical fatigue relief and memory improvement effects. Dihydromyricetin is the main flavonoid compound in the rattan tea plant. Studies have shown that dihydromyricetin has antioxidant, anti-tumor, anti-inflammatory and alcohol sobering functions. At present, there are few studies on the alcohol sobering effect of Cistanche deserticola polysaccharides, and there has been no report on the combined use of Cistanche deserticola polysaccharides and dihydromyricetin to enhance the alcohol sobering ability of dihydromyricetin. At present, people usually use chemical composition drugs such as hydrochlorothiazide tablets and furosemide tablets to sober up, but these drugs have certain side effects on the human body. Therefore, it is very meaningful to screen out certain ingredients from plant resources that are both medicinal and edible and prepare a more effective hangover-relieving compound extract. Summary of the invention

[0003] In view of this, the present invention aims to solve the problem of lack of hangover-relieving complex products using polysaccharides from traditional Chinese medicines with medicinal and edible properties as main raw materials, and provides a composite extract with hangover-relieving effect and a preparation method thereof.

[0004] The technical solution of the present invention is achieved as follows: The present invention provides a method for preparing a composite extract having the effect of sobering up, comprising the following steps:

[0005] Step 1, coarsely crushing Cistanche deserticola to obtain Cistanche deserticola powder, then using 150-250 times of pure water for stirring extraction, collecting the extract after filtering, and concentrating to 1 / (75-100) of the original volume to obtain a concentrated Cistanche deserticola crude polysaccharide extract;

[0006] Step 2, adding 95% ethanol solution to the crude polysaccharide extract of Cistanche deserticola until the ethanol concentration in the system is 30%-40%, standing overnight, centrifuging to remove the precipitate, collecting the supernatant after centrifugation, and using 95% ethanol solution to adjust the ethanol concentration of the system to 70%-80%, standing, and centrifuging to collect the precipitate;

[0007] Step 3: dilute the precipitate obtained in step 2 with pure water to a polysaccharide concentration of 150-350 mg / L, add 1%-1.5% papain by weight of the precipitate, react at low temperature for a period of time, inactivate the enzyme at high temperature, and concentrate to 1 / (30-50) of the original volume;

[0008] Step 4, the concentrated sample obtained in step 2 is loaded into a resin column filled with DEAE Seplife A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, and the 0.3 mol / L sodium chloride solution elution portion is collected, dialyzed with a dialysis bag, and freeze-dried to obtain Cistanche polysaccharide;

[0009] Step 5: Mix the Cistanche deserticola polysaccharide obtained in step 4 with dihydromyricetin in a mass ratio of (10-20):1, add the mixture into 1000 times volume of ultrapure water and perform ultrasonic treatment for a period of time;

[0010] Step 6: Add the mixed solution after ultrasonic treatment in step 5 into a high-pressure homogenizer for high-pressure homogenization, collect the mixed solution and dry it to obtain a Cistanche polysaccharide-dihydromyricetin complex.

[0011] In the above step 4, the results of absorbance test of sodium chloride eluents of different concentrations and corresponding eluents according to the alcohol metabolism enzyme alcohol dehydrogenase and acetaldehyde dehydrogenase activity detection experiment are shown in Table 1.

[0012] In some embodiments, in step 1, the extraction temperature is 80-90° C., the extraction time is 2.0-3.0 h, and the number of extractions is 1-3 times.

[0013] In some embodiments, in step 2, the centrifugation speed is 4000-6000 rpm, and the centrifugation time is 5-15 min.

[0014] In some embodiments, in step three, the low-temperature reaction temperature is 30-50°C, the enzyme inactivation temperature is 95-100°C, and the enzyme inactivation time is 5-15 min.

[0015] In some embodiments, in step 4, the elution flow rate of the sodium chloride solution is 0.8-1.2 BV / h, and the dialysis bag specification is 8000-10000 Da.

[0016] In some embodiments, in step five, the mass ratio of sample 4 to dihydromyricetin is 10-20:1, the ultrasonic power is 120-140 W, and the ultrasonic time is 15-30 min.

[0017] In some embodiments, in step six, the high-pressure homogenization pressure is 150-250 MPa, and the number of homogenization times is 2-4 times.

[0018] In some embodiments, the hangover-relieving ability of the Cistanche deserticola polysaccharide-dihydromyricetin complex obtained in step six is ​​significantly stronger than that of a dihydromyricetin solution at the same concentration.

[0019] In a second aspect, the present invention also provides a composite extract having the effect of sobering up, which is prepared by the above method.

[0020] In a third aspect, the present invention also provides an application of the above-mentioned composite extract with hangover-relief effect in preparing a hangover-relief product.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The invention uses Cistanche polysaccharide as a main component. Compared with a single dihydromyricetin solution with the same concentration, the obtained Cistanche polysaccharide-dihydromyricetin complex has a stronger alcohol sobering ability, and the preparation process is simple and efficient. The Cistanche polysaccharide and dihydromyricetin components have a synergistic effect.

[0023] The Cistanche deserticola and dihydromyricetin used in the invention both belong to or come from Chinese medicinal materials that are both edible and medicinal, and no toxic organic solvent is used in the preparation process, so the preparation process is green and pollution-free. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0025] Figure 1 This is a diagram of the separation and purification of Cistanche deserticola polysaccharide components in the eluents of different concentrations of sodium chloride in step 4 of the present invention.

[0026] In the figure: After verification, the target Cistanche polysaccharide was obtained after the elution portion of 0.3 mol / L sodium chloride solution was dialyzed and dried. DETAILED DESCRIPTION

[0027] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0028] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of this application, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0029] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the embodiments of the present invention belong. If the definitions set forth in this section are contrary to or otherwise inconsistent with the definitions set forth in the patents, patent applications, published patent applications, and other publications incorporated herein by reference, the definitions listed in this section take precedence over the definitions incorporated herein by reference.

[0030] Unless otherwise specified, the methods used in the following examples are all conventional methods. Unless otherwise specified, the materials, reagents and instruments used are all conventional materials, reagents and instruments in the art, and can be obtained by those skilled in the art through commercial channels.

[0031] When an amount, concentration or other value or parameter is expressed as a range, a preferred range or a range defined by a series of upper preferred values ​​and lower preferred values, this should be understood as specifically disclosing all ranges formed by any pairing of any range upper limit or preferred value with any range lower limit or preferred value, regardless of whether the range is disclosed separately. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted as including the range "1 to 4", "1 to 3", "1 to 2", "1 to 2 and 4 to 5", "1 to 3 and 5", etc. When a numerical range is described herein, unless otherwise stated, the range is intended to include its end values ​​and all integers and fractions within the range. In the present specification and claims, range definitions can be combined and / or interchanged, and if not otherwise stated, these ranges include all subranges contained therein.

[0032] Example 1

[0033] This embodiment provides a method for preparing a composite extract having the effect of sobering up, and the method steps are as follows:

[0034] (1) First, the Cistanche deserticola was coarsely crushed to obtain 1 kg of crushed Cistanche deserticola powder, and then 150 L of pure water was used to extract 3 times at 90°C, each extraction was 3.0 hours, filtered, the extract was collected, and then concentrated to 4.5 L; 95% ethanol solution was added to the system to an ethanol concentration of 40%, and the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 6000 rpm / min for 15 minutes; then 4.47 L of the supernatant after centrifugation was collected, and the ethanol concentration of the system was adjusted to 70% with 95% ethanol solution, and the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 4000 rpm / min for 5 minutes, and 10 g of the precipitate was collected; the precipitate was dissolved with pure water, the polysaccharide concentration was adjusted to 150 mg / L, 0.1 g of papain was added, and after reacting at 35°C for a period of time, the enzyme was inactivated at 95°C for 5 minutes, and the extract was concentrated to 0.6 L; the concentrate was loaded with DEAE Seplife The mixture was put into a resin column filled with A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, with an elution flow rate of 0.8 BV / h. The elution portion with 0.3 mol / L sodium chloride solution was collected, dialyzed with an 8000Da dialysis bag, and freeze-dried to obtain 2.5 g of Cistanche polysaccharide.

[0035] (2) 2.5 g of the obtained Cistanche polysaccharide and 0.25 g of dihydromyricetin were mixed, added to 2.75 L of ultrapure water, and ultrasonicated for 15 min at an ultrasonic power of 120 W. The ultrasonicated Cistanche polysaccharide-dihydromyricetin mixed solution was homogenized twice under a pressure of 150 MPa, and finally vacuum dried to obtain 2.51 g of a composite extract of Cistanche polysaccharide and dihydromyricetin.

[0036] Example 2

[0037] This embodiment provides a method for preparing a composite extract having the effect of sobering up, and the method steps are as follows:

[0038] (1) First, the Cistanche deserticola was coarsely crushed to obtain 1 kg of crushed Cistanche deserticola powder, and then 250 L of pure water was used to extract at 80°C for 1.0 h, filtered, the extract was collected, and then concentrated to 2.5 L; 95% ethanol solution was added to the system to an ethanol concentration of 30%, the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 6000 rpm / min for 15 min; then 2.47 L of the supernatant after centrifugation was collected, and the ethanol concentration of the system was adjusted to 80% with 95% ethanol solution, the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 6000 rpm / min for 15 min, and 9.5 g of precipitate was collected; the precipitate was dissolved with pure water, the polysaccharide concentration was adjusted to 350 mg / L, 0.14 g of papain was added, the reaction was carried out at 50°C for a period of time, the enzyme was inactivated at 100°C for 15 min, and the system was concentrated to 0.52 L; the concentrate was loaded with DEAE Seplife The product was put into a resin column filled with A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, with an elution flow rate of 1.2 BV / h. The 0.3 mol / L sodium chloride solution elution portion was collected, dialyzed with an 8000Da dialysis bag, and freeze-dried to obtain 2.13 g of Cistanche polysaccharide.

[0039] (2) 2.13 g of the obtained Cistanche polysaccharide and 0.1065 g of dihydromyricetin were mixed, added to 2.237 L of ultrapure water, and ultrasonicated for 30 min at an ultrasonic power of 140 W. The ultrasonicated Cistanche polysaccharide-dihydromyricetin mixed solution was homogenized 4 times under a pressure of 250 MPa, and finally vacuum dried to obtain 2.01 g of a composite extract of Cistanche polysaccharide and dihydromyricetin.

[0040] Example 3

[0041] This embodiment provides a method for preparing a composite extract having the effect of sobering up, and the method steps are as follows:

[0042] (1) First, the Cistanche deserticola was coarsely crushed to obtain 1 kg of crushed Cistanche deserticola powder, and then 200 L of pure water was used to extract twice at 85°C, each extraction was 1.5 hours, filtered, the extract was collected, and then concentrated to 2.3 L; 95% ethanol solution was added to the system to an ethanol concentration of 35%, and the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 5000 rpm / min for 10 minutes; then 2.28 L of the supernatant after centrifugation was collected, and the ethanol concentration of the system was adjusted to 75% with 95% ethanol solution, and the system was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 5000 rpm / min for 10 minutes, and 9.6 g of precipitate was collected; the precipitate was dissolved with pure water, the polysaccharide concentration was adjusted to 300 mg / L, 0.11 g of papain was added, and after reacting at 45°C for a period of time, the enzyme was inactivated at 95°C for 10 minutes, and the extract was concentrated to 0.50 L; the concentrate was loaded with DEAE Seplife The product was put into a resin column filled with A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, with an elution flow rate of 1.0 BV / h. The 0.3 mol / L sodium chloride solution elution portion was collected, dialyzed with a 10000 Da dialysis bag, and freeze-dried to obtain 2.11 g of Cistanche polysaccharide.

[0043] (2) 2.11 g of the obtained Cistanche polysaccharide was mixed with 0.14 g of dihydromyricetin, added to 2.25 L of ultrapure water, and ultrasonicated for 25 min at an ultrasonic power of 130 W. The ultrasonicated Cistanche polysaccharide-dihydromyricetin mixed solution was homogenized 3 times under a pressure of 200 MPa, and finally vacuum dried to obtain 2.01 g of a composite extract of Cistanche polysaccharide and dihydromyricetin.

[0044] Comparative Example 1

[0045] The difference between this comparative example and Example 1 is that ultrasonic treatment, high pressure homogenization and drying are not performed, and the remaining steps are the same as those of Example 1. The specific steps are:

[0046] First, the herb was coarsely crushed to obtain 1 kg of crushed herb powder, and then 150 L of pure water was used to extract 3 times at 90 ° C, each extraction was 3.0 hours, filtered, the extract was collected, and then concentrated to 4.5 L; 95% ethanol solution was added to the system to make the ethanol concentration 40%, and the mixture was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 6000 rpm / min for 15 minutes; then 4.47 L of the supernatant after centrifugation was collected, and the ethanol concentration of the system was adjusted to 70% with 95% ethanol solution, and the mixture was allowed to stand overnight, and centrifuged in a centrifuge at a speed of 4000 rpm / min for 5 minutes, and 10 g of the precipitate was collected; the precipitate was dissolved with pure water, the polysaccharide concentration was adjusted to 150 mg / L, 0.1 g of papain was added, and after reacting at 35 ° C for a period of time, the enzyme was inactivated at 95 ° C for 5 minutes, and the mixture was concentrated to 0.6 L; the concentrate was loaded with DEAE Seplife The mixture was put into a resin column filled with A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, with an elution flow rate of 0.8 BV / h. The elution portion with 0.3 mol / L sodium chloride solution was collected, dialyzed with an 8000Da dialysis bag, and freeze-dried to obtain 2.5 g of Cistanche polysaccharide.

[0047] Comparative Example 2

[0048] 0.25 g of dihydromyricetin was added to 2.75 L of ultrapure water and ultrasonicated for 15 min at an ultrasonic power of 120 W. The ultrasonicated dihydromyricetin was homogenized twice at a pressure of 150 MPa and finally vacuum dried to obtain 0.19 g of the sample.

[0049] Alcohol metabolism enzymes alcohol dehydrogenase and acetaldehyde dehydrogenase activity detection experiment

[0050] instrument:

[0051] Multifunctional microplate reader Synergy H1 (with fluorescence intensity, absorbance, and chemiluminescence modules) (BioTek); automatic pipetting and dispensing system Bioteck Precesion PRC 384U (8 channels, 12 channels) (BioTek); vortex mixer; 96-well microplate (corning 3599); Eppendorf multichannel pipette; Eppendorf pipette (100 μL, 1000 μL); Eppendorf tube (amber, 2 mL)

[0052] Reagents:

[0053] Sodium pyrophosphate (Chinese medicine), ethanol, hydrochloric acid (Chinese medicine), alcohol dehydrogenase (ADH), glycerol (AR) (Chinese medicine), ultrapure water, acetaldehyde dehydrogenase (ALDH, sigma-aldrich), dithiothreitol (DTT, aladin), nicotinamide adenine dinucleotide (NAD+, aladin), acetaldehyde (AL, Beijing Lingfeng)

[0054] Experimental steps:

[0055] ①Sample preparation

[0056] The samples in Examples 1-3 and Comparative Examples 1-2 were taken respectively, and the samples in Examples 1-3 and Comparative Example 1 were configured into solutions with a final concentration of 2 mg / mL using ultrapure water. The concentration of dihydromyricetin in the 2 mg / mL sample in Example 1 was then determined using a liquid chromatograph, and the sample in Comparative Example 2 was configured into a solution with the same concentration of dihydromyricetin as that in the sample in Example 1 using ultrapure water. The final concentration of the sample in Comparative Example 2 was calculated to be 0.17 mg / mL.

[0057] ②Add sample

[0058] Specific operation steps for the determination of alcohol dehydrogenase (ADH) activity: the reaction wells are set as control wells BLK, blank control wells EMP, sample wells SPL, and sample control wells SPLC. Add 100μL of 50mmol / L sodium pyrophosphate buffer solution (pH 8.8), 30μL of sample solution, 30μL of 2.0U / mL alcohol dehydrogenase, and 30μL of 20% ethanol solution to a transparent 96-well plate, and then quickly add 30μL of 2.0mmol / L NAD+ solution. In the microplate reader, you can start monitoring the reaction at 340nm for 90min and measure its 340nm absorbance intensity. Use the software equipped with the microplate reader to record the absorbance, and the initial absorbance value is recorded as R1. After that, it is measured once every minute, and the absorbance is recorded as R1, R2...R91 respectively. When Rn reaches the maximum value and is stable, the reaction ends, and the reaction time is tmax. The sample activity is the net area under the curve.

[0059] Specific operation steps for the determination of aldehyde dehydrogenase (ALDH) activity: Add 75 μL of 100 mmol / L potassium phosphate buffer solution (pH 8.0), 40 μL of 0.4 mmol / L dithiothreitol (DTT), 30 μL of 1 U / mL aldehyde dehydrogenase, 30 μL of the test sample solution (or buffer solution), and 0.05 mol / L into the well plate. Incubate at 37 °C for 30 min in the microplate reader, and then quickly add 30 μL of 0.05 mmol / L acetaldehyde solution and 30 μL of 2.0 mmol / L NAD+ solution. After shaking well, start the measurement immediately. Use the software equipped with the microplate reader to record the absorbance. The initial absorbance value is recorded as f1, and then measure once every minute for 90 minutes. The absorbances are recorded as f1, f2... f91 respectively. When fx reaches the maximum value and is stable, it indicates the end of the reaction. The reaction time is tmax, and its Δ absorbance value = fn - f0 (n = 1, 2, 3... 91).

[0060] ③ Calculation formula

[0061] Net AUC blank = AUC - Blk - AUC - Emp,

[0062] Net AUC sample = AUC - SPL - AUC - SPLC

[0063] Medicinal materials with aldehyde dehydrogenase / ethanol dehydrogenase activation effect: Net AUC sample > Net AUC blank

[0064] Medicinal materials with aldehyde dehydrogenase / ethanol dehydrogenase inhibition effect: Net AUC sample < Net AUC blank

[0065] Medicinal materials with no effect on aldehyde dehydrogenase / ethanol dehydrogenase: Net AUC sample ≈ Net AUC blank (±5%)

[0066] Inhibition (activation) rate (%) of the sample = (Net AUC blank - Net AUC sample) / Net AUC blank * 100%

[0067] ④ Experimental results

[0068] Table 1 Effects of samples on ethanol dehydrogenase and aldehyde dehydrogenase in different examples and comparative examples

[0069]

[0070] Note: Positive values indicate inhibition, and negative values indicate activation.

[0071] Alcohol dehydrogenase and acetaldehyde dehydrogenase are two key enzymes that decompose alcohol in the human body. When the two enzymes are activated, it means that the activated substance has a hangover-relieving effect on the human body. As can be seen from Table 1, the sample measurement results in Examples 1-3 are all negative values, and the negative value indicates that the substance has an activation effect on alcohol dehydrogenase and acetaldehyde dehydrogenase, so the samples in Examples 1-3 have an activation effect on acetaldehyde dehydrogenase and alcohol dehydrogenase, further illustrating that the samples in the embodiments have the ability to relieve alcohol. The sample measurement result in Comparative Example 1 is a positive value, which shows that Cistanche deserticola polysaccharide has no activation effect on acetaldehyde dehydrogenase and alcohol dehydrogenase, and does not have a hangover-relieving effect. And the single dihydromyricetin measurement result in Comparative Example 2 is also a negative value, indicating that dihydromyricetin has an activation effect on acetaldehyde dehydrogenase and alcohol dehydrogenase, and has a hangover-relieving effect. In this experiment, the content of dihydromyricetin in Example 1 and Comparative Example 2 is the same. By comparing the absolute values ​​of acetaldehyde dehydrogenase and alcohol dehydrogenase assay values ​​of the two, it is found that the absolute values ​​of acetaldehyde dehydrogenase and alcohol dehydrogenase assay values ​​of Example 1 of the present invention are much higher than those of Comparative Example 2, which indicates that the hangover-relieving effect of the Cistanche polysaccharide-dihydromyricetin composite extract in Example 1 of the present invention is much stronger than that of single dihydromyricetin (Comparative Example 2), reflecting the synergistic effect of the two substances.

[0072] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a composite extract having the effect of sobering up, characterized in that: The steps include: Step 1, coarsely crushing Cistanche deserticola to obtain Cistanche deserticola powder, then using 150-250 times of pure water for stirring extraction, collecting the extract after filtering, and concentrating to 1 / (75-100) of the original volume to obtain a concentrated Cistanche deserticola crude polysaccharide extract; Step 2, adding 95% ethanol solution to the crude polysaccharide extract of Cistanche deserticola until the ethanol concentration in the system is 30%-40%, standing overnight, centrifuging to remove the precipitate, collecting the supernatant after centrifugation, and using 95% ethanol solution to adjust the ethanol concentration of the system to 70%-80%, standing, and centrifuging to collect the precipitate; Step 3: dilute the precipitate obtained in step 2 with pure water to a polysaccharide concentration of 150-350 mg / L, add 1%-1.5% papain by weight of the precipitate, react at low temperature for a period of time, inactivate the enzyme at high temperature, and concentrate to 1 / (30-50) of the original volume; Step 4, the concentrated sample obtained in step 2 is loaded into a resin column filled with DEAE Seplife A25 filler, and then eluted with 0, 0.1, 0.3, and 0.5 mol / L sodium chloride solutions in sequence, and the 0.3 mol / L sodium chloride solution elution portion is collected, dialyzed with a dialysis bag, and freeze-dried to obtain Cistanche polysaccharide; Step 5: Mix the Cistanche deserticola polysaccharide obtained in step 4 with dihydromyricetin in a mass ratio of (10-20):1, add the mixture into 1000 times volume of ultrapure water and perform ultrasonic treatment for a period of time; Step 6: Add the mixed solution after ultrasonic treatment in step 5 into a high-pressure homogenizer for high-pressure homogenization, collect the mixed solution and dry it to obtain a Cistanche polysaccharide-dihydromyricetin complex.

2. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step 1, the extraction temperature is 80-90° C., the extraction time is 2.0-3.0 h, and the number of extractions is 1-3 times.

3. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step 2, the centrifugal speed is 4000-6000 rpm, and the centrifugal time is 5-15 min.

4. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step three, the low temperature reaction temperature is 30-50°C, the enzyme inactivation temperature is 95-100°C, and the enzyme inactivation time is 5-15 minutes.

5. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step 4, the elution flow rate of the sodium chloride solution is 0.8-1.2 BV / h, and the dialysis bag specification is 8000-10000 Da.

6. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step 5, the mass ratio of sample 4 to dihydromyricetin is 10-20:1, the ultrasonic power is 120-140 W, and the ultrasonic time is 15-30 min.

7. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: In step six, the high-pressure homogenization pressure is 150-250 MPa, and the homogenization times are 2-4 times.

8. The method for preparing the composite extract having the effect of sobering up according to claim 1, characterized in that: The hangover-relieving ability of the Cistanche deserticola polysaccharide-dihydromyricetin complex obtained in step six is ​​significantly stronger than that of the dihydromyricetin solution at the same concentration.

9. A composite extract having the effect of sobering up, characterized in that: The preparation method is described in any one of claims 1 to 8.

10. Use of the composite extract prepared by the preparation method according to any one of claims 1 to 8 or the composite extract according to claim 9 in preparing a hangover sobering product.